Capricor Therapeutics (CAPR) Reports Q4 Loss of $0.21/Share

Capricor Therapeutics (NASDAQ: CAPR) reported Q4 EPS of ($0.21), versus ($0.21) reported last year.

For earnings history and earnings-related data on Capricor Therapeutics (CAPR) click here.

You May Also Be Interested In

• Kaos Capital pushes for board changes at Capricor Therapeutics
• Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
• Bernstein remains bullish on SpaceX but sees challenges in telecom ambitions